Skip to main content

Military Health System

Development of WRAIR’s Pan-Coronavirus Vaccine Shows Promise

Image of A vial of spike ferritin nanoparticle WRAIR's COVID-19 vaccine. A vial of spike ferritin nanoparticle (SpFN), WRAIR’s COVID-19 vaccine. Built on a ferritin platform, the vaccine offers a flexible approach to targeting multiple variants of the virus that causes COVID-19 and potentially other coronaviruses as well (Photo by: Mike Walters, Walter Reed Army Institute of Research).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses.

Scientists in WRAIR's Emerging Infectious Diseases Branch (EIDB) developed the SpFN nanoparticle vaccine, based on a ferritin platform, as part of a forward-thinking "pan-SARS" strategy that aims to address the current pandemic and acts as a first line of defense against variants of concern and similar viruses that could emerge in the future.

"The accelerating emergence of human coronaviruses throughout the past two decades and the rise of SARS-CoV-2 variants, including most recently Omicron, underscore the continued need for next-generation preemptive vaccines that confer broad protection against coronavirus diseases," said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at WRAIR, co-inventor of the vaccine and the Army lead for SpFN. "Our strategy has been to develop a 'pan-coronavirus' vaccine technology that could potentially offer safe, effective and durable protection against multiple coronavirus strains and species."

Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by the original strain of SARS-CoV-2 and induces highly-potent and broadly-neutralizing antibody responses against major SARS-CoV-2 variants of concern including the SARS-CoV-1 virus that emerged in 2002.

SpFN entered Phase 1 human trials in April 2021. Early analyses, expected to conclude this month, will provide insights into whether SpFN's potency and breadth, as demonstrated in preclinical trials, will carry over into humans. The data will also allow researchers to compare SpFN's immune profile to that of other COVID-19 vaccines already authorized for emergency use.

"This vaccine stands out in the COVID-19 vaccine landscape," Modjarrad said. "The repetitive and ordered display of the coronavirus spike protein on a multi-faced nanoparticle may stimulate immunity in such a way as to translate into significantly broader protection."

WRAIR developed a secondary candidate vaccine, a SARS-CoV-2 Spike Receptor-Binding Domain Ferritin Nanoparticle (RFN) vaccine, which targets a smaller part of the coronavirus Spike protein than the SpFN vaccine. Results from a study, published recently in the Proceedings of the National Academy of Sciences, show that this vaccine potentially offers similar protection against an array of SARS-CoV-2 variants and SARS-CoV-1.

"The RFN vaccine candidate is more compact and has some natural advantages as we try to increase the immune response against multiple coronaviruses using a single vaccine platform, so it is still under consideration as part of our pan-coronavirus vaccine development pipeline," said Dr. Gordon Joyce, WRAIR structural biologist and vaccine co-inventor.

"The threat from COVID-19 continues as it evolves, and eventually there will be other emerging disease threats," said Dr. Nelson Michael, director of the Center for Infectious Diseases Research at WRAIR. "Our investment in developing a next generation vaccine is an important step towards getting ahead of COVID-19 and future disease threats."

You also may be interested in...

MHS Minute | Nov 2022

Video
12/12/2022
MHS Minute | Nov 2022

The latest MHS Minute focuses on highlights from DHA Director Lt. Gen. Ronald J. Place’s final virtual town hall with the workforce, Nov. 16, 2022. The discussion included the agency’s biggest accomplishments over the past three years and the impact of COVID-19 on DHA’s reputation and approach to health care delivery.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus

Does CSM Gragg Have COVID-19?

Video
2/9/2022
Does CSM Gragg Have COVID-19?

CSM Gragg demonstrates how to use a COVID-19 at home rapid test.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | At-Home COVID-19 Tests | Coronavirus & the MHS Response

CSM Gragg Vaccine Statement

Video
8/24/2021
CSM Gragg Vaccine Statement

CSM Gragg shares his personal story dealing with COVID and the loss associated with it and urges all to take precautions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Lt. Gen. Place and Command Sgt. Maj. Gragg on Getting Vaccinated

Video
8/16/2021
Lt. Gen. Place and Command Sgt. Maj. Gragg on Getting Vaccinated

DHA Director Lt. Gen. Ron Place and DHA Senior Enlisted Leader Command Sgt. Maj. Michael Gragg talk about how getting vaccinated against COVID-19 is more important than ever.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

The Battle Against the COVID-19 Delta Variant

Video
6/29/2021
The Battle Against the COVID-19 Delta Variant

Like our enemies in the past, the coronavirus has adapted and we're now dealing with the most transmissible variant yet, Delta. The fight can be won with vaccination. If you're not yet vaccinated against the coronavirus, go get your shot today. Otherwise you're at high risk for severe disease, hospitalization, and death.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

The Delta Variant: A New Reason to Get Vaccinated

Video
6/25/2021
The Delta Variant: A New Reason to Get Vaccinated

Are you a service member age 18 to 30? Are you unvaccinated? You may be entitled to severe disease, hospitalization, and death. To avoid these options, get vaccinated today!

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Are mRNA vaccines safe?

Video
5/28/2021
Are mRNA vaccines safe?

Dr. LC Collins explains the years of research and ongoing monitoring to show how mRNA vaccines are safe and effective.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Facts: Breastfeeding after the COVID-19 Vaccine

Video
5/28/2021
VAX Facts: Breastfeeding after the COVID-19 Vaccine

Dr. LC Collins encourages people who are breastfeeding to get the vaccine. Since the vaccine doesn't contain live virus, you can't pass COVID to your baby.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

What is an mRNA vaccine?

Video
5/28/2021
What is an mRNA vaccine?

Dr. LC Collins explains how mRNA vaccines work to protect you from COVID-19.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Facts: Do I Need the Vaccine if I Had COVID?

Video
5/28/2021
VAX Facts: Do I Need the Vaccine if I Had COVID?

Dr. LC Collins talks about the importance of getting vaccinated even if you already had COVID. We're not sure how long natural immunity lasts, so getting vaccinated is the best way to protect yourself.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

VAX Facts: Which Vaccine is Right for Me?

Video
5/28/2021
VAX Facts: Which Vaccine is Right for Me?

Dr. LC Collins talks about the importance of getting the first vaccine available to you. Don't hold out for a certain brand; they're all safe and effective.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vax Facts | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

Vax Facts: Risk and Precautions

Video
5/20/2021
Vax Facts: Risk and Precautions

If you're fully vaccinated, there are options for safer activities. Watch to learn what activities you can resume once you're fully vaccinated.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

Vax Facts: I'm fully vaccinated. What can I do?

Video
5/20/2021
Vax Facts: I'm fully vaccinated. What can I do?

If you're fully vaccinated, there are options for safer activities. Watch to learn what activities you can resume once you're fully vaccinated.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

Vax Facts: Recommendations for Pregnancy

Video
5/20/2021
Vax Facts: Recommendations for Pregnancy

The COVID vaccine is recommended for pregnant people. Watch to learn how your doctor can help you make the best decision for you and your baby.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Vaccine Efforts

MHS Celebrates National Hospital Week

Video
5/12/2021
MHS Celebrates National Hospital Week

During National Hospital Week, we highlight all of the training efforts and safety protocols the Military Health System has put in place during the COVID-19 pandemic.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Mental Health: Seeking Care with TRICARE | May
<< < 1 2 3 4 > >> 
Showing results 1 - 15 Page 1 of 4
Refine your search
Last Updated: January 31, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery